Desjardins Global Asset Management’s West Pharmaceutical WST Stock Holding History

Desjardins Global Asset Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$166K	Sell	472 -270	-36%	-$95.6K	0.02%	383
2023 Q3	$278K	Sell	742 -114	-13%	-$44.1K	0.03%	327
2023 Q2	$327K	Buy	856 +26	+3%	+$9.29K	0.04%	367
2023 Q1	$287K	Buy	830 +141	+20%	+$41.2K	0.04%	358
2022 Q4	$162K	Sell	689 -1,255	-65%	-$297K	0.03%	361
2022 Q3	$477K	Hold	1,944	–	–	0.06%	233
2022 Q2	$588K	Sell	1,944 -1,466	-43%	-$477K	0.08%	212
2022 Q1	$1.4M	Sell	3,410 -277	-8%	-$108K	0.12%	161
2021 Q4	$1.73M	Buy	+3,687	New	+$1.59M	0.15%	157

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Desjardins Global Asset Management's WST Position: Q4 2023 in Review

Desjardins Global Asset Management reduced its West Pharmaceutical (WST) stake by 36% in Q4 2023, selling an estimated $95.6K and leaving 472 shares worth $166K. The position accounts for 0.02% of the portfolio, ranked #383.

Desjardins Global Asset Management first reported a position in WST in Q4 2021 and has held it in 9 quarters since. The position peaked at $1.73M in Q4 2021. 782 funds tracked by Wall St. Rank hold WST as of Q4 2023.

Desjardins Global Asset Management held 472 shares of West Pharmaceutical worth $166K as of Q4 2023.
Desjardins Global Asset Management sold 270 West Pharmaceutical shares in Q4 2023, an estimated $95.6K.
West Pharmaceutical made up 0.02% of Desjardins Global Asset Management's portfolio in Q4 2023, its #383 holding.
Desjardins Global Asset Management first reported a position in West Pharmaceutical in Q4 2021 and has held it in 9 quarters since.
Desjardins Global Asset Management's West Pharmaceutical position peaked at $1.73M in Q4 2021.
782 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2023.

Based on Desjardins Global Asset Management's 13F filing for Q4 2023, filed 30 Jan 2024.